These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 33838612)

  • 61. Quasi-SMILES: quantitative structure-activity relationships to predict anticancer activity.
    Toropova AP; Toropov AA
    Mol Divers; 2019 May; 23(2):403-412. PubMed ID: 30306392
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Use of the Monte Carlo Method for OECD Principles-Guided QSAR Modeling of SIRT1 Inhibitors.
    Kumar A; Chauhan S
    Arch Pharm (Weinheim); 2017 Jan; 350(1):. PubMed ID: 28025857
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The sequence of amino acids as the basis for the model of biological activity of peptides.
    Toropova AP; Raškova M; Raška I; Toropov AA
    Theor Chem Acc; 2021; 140(2):15. PubMed ID: 33500680
    [TBL] [Abstract][Full Text] [Related]  

  • 64. OCWLGI descriptors: theory and praxis.
    Toropov AA; Toropova AP; Benfenati E; Gini G
    Curr Comput Aided Drug Des; 2013 Jun; 9(2):226-32. PubMed ID: 23700994
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Correlation intensity index: Building up models for mutagenicity of silver nanoparticles.
    Toropov AA; Toropova AP
    Sci Total Environ; 2020 Oct; 737():139720. PubMed ID: 32554036
    [TBL] [Abstract][Full Text] [Related]  

  • 66. QSAR modelling for mutagenic potency of heteroaromatic amines by optimal SMILES-based descriptors.
    Toropov AA; Toropova AP; Benfenati E
    Chem Biol Drug Des; 2009 Mar; 73(3):301-12. PubMed ID: 19207466
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Development of prediction model for fructose- 1,6- bisphosphatase inhibitors using the Monte Carlo method.
    Manisha ; Chauhan S; Kumar P; Kumar A
    SAR QSAR Environ Res; 2019 Mar; 30(3):145-159. PubMed ID: 30777782
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Development and design of novel cardiovascular therapeutics based on Rho kinase inhibition-In silico approach.
    Ćirić Zdravković S; Pavlović M; Apostlović S; Koraćević G; Šalinger Martinović S; Stanojević D; Sokolović D; Veselinović AM
    Comput Biol Chem; 2019 Apr; 79():55-62. PubMed ID: 30716601
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In silico development of anesthetics based on barbiturate and thiobarbiturate inhibition of GABA
    Stošić B; Janković R; Stošić M; Marković D; Stanković D; Sokolović D; Veselinović AM
    Comput Biol Chem; 2020 Oct; 88():107318. PubMed ID: 32622179
    [TBL] [Abstract][Full Text] [Related]  

  • 70. QSAR model for blood-brain barrier permeation.
    Toropov AA; Toropova AP; Beeg M; Gobbi M; Salmona M
    J Pharmacol Toxicol Methods; 2017 Nov; 88(Pt 1):7-18. PubMed ID: 28476566
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Monte carlo method-based QSAR modeling of penicillins binding to human serum proteins.
    Veselinović JB; Toropov AA; Toropova AP; Nikolić GM; Veselinović AM
    Arch Pharm (Weinheim); 2015 Jan; 348(1):62-7. PubMed ID: 25408278
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hydroxyethylamine derivatives as HIV-1 protease inhibitors: a predictive QSAR modelling study based on Monte Carlo optimization.
    Bhargava S; Adhikari N; Amin SA; Das K; Gayen S; Jha T
    SAR QSAR Environ Res; 2017 Dec; 28(12):973-990. PubMed ID: 29072112
    [TBL] [Abstract][Full Text] [Related]  

  • 73. QSAR models for toxicity of organic substances to Daphnia magna built up by using the CORAL freeware.
    Toropova AP; Toropov AA; Benfenati E; Gini G
    Chem Biol Drug Des; 2012 Mar; 79(3):332-8. PubMed ID: 22136580
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Monte Carlo method based QSAR modeling of maleimide derivatives as glycogen synthase kinase-3β inhibitors.
    Živković JV; Trutić NV; Veselinović JB; Nikolić GM; Veselinović AM
    Comput Biol Med; 2015 Sep; 64():276-82. PubMed ID: 26257010
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Quantitative Structure-Activity Relationship Study of Bitter Di-, Tri- and Tetrapeptides Using Integrated Descriptors.
    Xu B; Chung HY
    Molecules; 2019 Aug; 24(15):. PubMed ID: 31387305
    [TBL] [Abstract][Full Text] [Related]  

  • 76. QSAR Models for Nitrogen Containing Monophosphonate and Bisphosphonate Derivatives as Human Farnesyl Pyrophosphate Synthase Inhibitors Based on Monte Carlo Method.
    Kumar P; Kumar A; Sindhu J; Lal S
    Drug Res (Stuttg); 2019 Mar; 69(3):159-167. PubMed ID: 30036888
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Insights into antioxidant activity of 1-adamantylthiopyridine analogs using multiple linear regression.
    Worachartcheewan A; Nantasenamat C; Owasirikul W; Monnor T; Naruepantawart O; Janyapaisarn S; Prachayasittikul S; Prachayasittikul V
    Eur J Med Chem; 2014 Feb; 73():258-64. PubMed ID: 24412501
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Monte Carlo Method Based QSAR Studies of Mer Kinase Inhibitors in Compliance with OECD Principles.
    Kumar P; Kumar A
    Drug Res (Stuttg); 2018 Apr; 68(4):189-195. PubMed ID: 28992659
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Correlation intensity index: mathematical modeling of cytotoxicity of metal oxide nanoparticles.
    Ahmadi S; Toropova AP; Toropov AA
    Nanotoxicology; 2020 Oct; 14(8):1118-1126. PubMed ID: 32877261
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Statistical confidence for variable selection in QSAR models via Monte Carlo cross-validation.
    Konovalov DA; Sim N; Deconinck E; Vander Heyden Y; Coomans D
    J Chem Inf Model; 2008 Feb; 48(2):370-83. PubMed ID: 18232680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.